Use of nanodispersions in pharmaceutical end formulations
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 25, 2006
Grant Date -
Oct 9, 2003
app pub date -
May 6, 1999
filing date -
May 11, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A description is given of the use of a nanodispersion, which comprises (a) a membrane-forming molecule, (b) a coemulsifier and (c) a lipophilic component, in pharmaceutical end formulations, the nanodispersion being obtainable by (.alpha.) mixing the components (a), (b) and (c) until a homogeneous clear liquid is obtained, and (.beta.) adding the liquid obtained in step (.alpha.) to the water phase of the pharmaceutical end formulations, steps (.alpha.) and (.beta.) being carried out without any additional supply of energy. The nanodispersions used according to this invention are suitable as transport vehicles for pharmaceutical active agents.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully